pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·5h ago·1 min read
save

Oura to buy AI health chatbot firm Counsel Health for $625 million

Nov 10, 2026·read at STAT ↗DealPositive

Oura announced that it will acquire Counsel Health, a startup that builds clinical artificial‑intelligence tools, for a cash price of $625 million.

Counsel Health operates a conversational chatbot that helps users discuss health concerns and then routes them to a clinician for telehealth diagnosis and treatment.

The transaction underscores a growing interest in linking consumer wearable devices, such as Oura’s smart ring, with clinical care pathways and reflects confidence that AI‑driven chat interfaces will become a larger part of the healthcare ecosystem. Oura made the announcement shortly after postponing its planned public offering due to market uncertainty.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care”

read at STAT ↗
526 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLYUltragenyx Pharmaceutical Inc.
drugs
MOUNJAROZEPBOUNDtirzepatide
topics
Psychiatry & CNS2ApprovalGLP-1 receptorOphthalmologyRare DiseaseType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 1d agoFDA orders class-wide GLP-1 label update to include potential risk for rare eye diseaseBioSpace
  • 1d agoLilly to seek second sleep apnea approval after Foundayo reduces disease severity in Phase 3BioSpace
  • Oct 30Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting gameBioPharma Dive
  • Oct 19Should amylin have been obesity therapeutics’ primary target from the start?BioSpace